Guided Therapeutics Inc
GTHP· OTC
Filed Aug 14, 2012 · 10-Q · 45 days after period end · 0001121781-12-000273
| Metric | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|
| Revenue | $915.00K | $913.00K | $805.00K |
| Net Income | -$1.17M | -$496.00K | -$559.00K |
| EPS Diluted | -$0.02 | -$0.01 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Guided Therapeutics Inc · CIK 924515 · Engraved from SEC EDGAR
ended Jun 30, 2012 · filed Aug 14, 2012 · 45 d after period end